-+ 0.00%
-+ 0.00%
-+ 0.00%

KYVERNA THERAPEUTICS SHARES JUMP 39% AFTER CO'S CELL THERAPY MEETS MAIN GOAL OF MID-STAGE STUDY

Reuters·12/15/2025 14:31:32

Please log in to view news